189 related articles for article (PubMed ID: 2997680)
21. Epidermal growth factor receptor signaling enhanced by long-term medroxyprogesterone acetate treatment in endometrial carcinoma.
Zhao S; Chen X; Lu X; Yu Y; Feng Y
Gynecol Oncol; 2007 Apr; 105(1):45-54. PubMed ID: 17240435
[TBL] [Abstract][Full Text] [Related]
22. High progesterone receptor concentration in a variant of the ZR-75-1 human breast cancer cell line adapted to growth in oestrogen free conditions.
van den Berg HW; Martin J; Lynch M
Br J Cancer; 1990 Apr; 61(4):504-7. PubMed ID: 2139575
[TBL] [Abstract][Full Text] [Related]
23. Hormone receptors and enzymatic activities in human endometrial adenocarcinoma.
Dell'Acqua S; De Cicco Nardone F; Benedetto MT; Iacobelli S; Rossiello F; Bongiorno M; Margariti PA
Ann N Y Acad Sci; 1990; 595():334-47. PubMed ID: 2142874
[TBL] [Abstract][Full Text] [Related]
24. The effect of ethynyloestradiol and medroxyprogesterone acetate on the in vivo uptake and metabolism of 3H-oestradiol by breast tumour tissue in postmenopausal women.
Reed MJ; Beranek PA; Bonney RC; Ghilchik MW; James VH
Anticancer Res; 1987; 7(6):1265-9. PubMed ID: 2831795
[TBL] [Abstract][Full Text] [Related]
25. Failure of progestins to induce estradiol dehydrogenase activity in endometrial carcinoma, in vitro.
Satyaswaroop PG; Mortel R
Cancer Res; 1982 Apr; 42(4):1322-5. PubMed ID: 6949638
[TBL] [Abstract][Full Text] [Related]
26. Regulation of plasminogen activator inhibitor 1 expression by interaction of epidermal growth factor with progestin during decidualization of human endometrial stromal cells.
Lockwood CJ
Am J Obstet Gynecol; 2001 Apr; 184(5):798-804; discussion 804-5. PubMed ID: 11303186
[TBL] [Abstract][Full Text] [Related]
27. Stimulation of various 17 beta- and 20 alpha-hydroxysteroid dehydrogenase activities by progestins in human endometrium.
Tseng L; Gurpide E
Endocrinology; 1979 Jun; 104(6):1745-8. PubMed ID: 446393
[No Abstract] [Full Text] [Related]
28. Female sex steroid receptors in post menopausal endometrial carcinoma. Biochemical responses to antiestrogen and progestin.
Robel P; Gravanis A; Roger-Jallais L; Catelli MG; Binart N; George M; Laval C; Baulieu EE
Prog Clin Biol Res; 1984; 142():167-79. PubMed ID: 6709656
[No Abstract] [Full Text] [Related]
29. [Changes of sex steroid hormone receptors in rat uterine cytosol during experimental induction of endometrial carcinoma (author's transl)].
Nagasaka T
Acta Obstet Gynaecol Jpn; 1981 Jun; 33(6):757-66. PubMed ID: 6454322
[TBL] [Abstract][Full Text] [Related]
30. [Adjuvant hormone therapy in endometrial carcinoma: medroxyprogesterone acetate versus tamoxifen-medroxyprogesterone acetate sequential therapy].
Vavra N; Salzer H; Sevelda P; Breitenecker G; Czerwenka K; Kucera H
Gynakol Rundsch; 1990; 30(3):133-43. PubMed ID: 2147161
[TBL] [Abstract][Full Text] [Related]
31. Effects of mifepristone on proliferation and apoptosis of human endometrium in new users of medroxyprogesterone acetate.
Jain JK; Li A; Yang W; Minoo P; Felix JC
Hum Reprod; 2006 Mar; 21(3):798-809. PubMed ID: 16311300
[TBL] [Abstract][Full Text] [Related]
32. Effects of tibolone and its metabolites on Angiopoietin-1, Tie-2 and tumor necrosis factor-alpha mRNA in Ishikawa cells. Implication for tibolone's effects on the endometrium.
Mirkin S; Archer DF
Maturitas; 2007 Aug; 57(4):338-46. PubMed ID: 17478063
[TBL] [Abstract][Full Text] [Related]
33. Biochemical and histologic effects of sequential estrogen/progestin therapy on the endometrium of postmenopausal women.
Gibbons WE; Moyer DL; Lobo RA; Roy S; Mishell DR
Am J Obstet Gynecol; 1986 Feb; 154(2):456-61. PubMed ID: 3004222
[TBL] [Abstract][Full Text] [Related]
34. Contrasting actions of tamoxifen on endometrial and breast tumor growth in the athymic mouse.
Gottardis MM; Robinson SP; Satyaswaroop PG; Jordan VC
Cancer Res; 1988 Feb; 48(4):812-5. PubMed ID: 3338079
[TBL] [Abstract][Full Text] [Related]
35. Effects of estradiol with micronized progesterone or medroxyprogesterone acetate on risk markers for breast cancer in postmenopausal monkeys.
Wood CE; Register TC; Lees CJ; Chen H; Kimrey S; Cline JM
Breast Cancer Res Treat; 2007 Jan; 101(2):125-34. PubMed ID: 16841178
[TBL] [Abstract][Full Text] [Related]
36. The histochemistry of oestradiol-17 beta dehydrogenase in normal endometrium and endometrial carcinoma: a test to predict the sensitivity of endometrial carcinoma to progestogens: a preliminary report.
Lane G; Whitehead MI; King RJ
Br J Obstet Gynaecol; 1990 Aug; 97(8):742-4. PubMed ID: 2144769
[No Abstract] [Full Text] [Related]
37. Influence of tamoxifen-medroxyprogesterone sequential therapy on estrogen and progesterone receptor contents of breast cancer.
Noguchi S; Yamamoto H; Inaji H; Imaoka S; Koyama H
Jpn J Cancer Res; 1989 Mar; 80(3):244-8. PubMed ID: 2524460
[TBL] [Abstract][Full Text] [Related]
38. Regulation of estrogen and progestin receptor concentrations in an experimental rat prostatic carcinoma by estrogen, antiestrogen, and progesterone.
Mobbs BG; Johnson IE; DeSombre ER; Toth J; Hughes A
Cancer Res; 1987 May; 47(10):2645-51. PubMed ID: 3552202
[TBL] [Abstract][Full Text] [Related]
39. Hormone-resistant endometriosis following total abdominal hysterectomy and bilateral salpingo-oophorectomy: correlation with histology and steroid receptor content.
Metzger DA; Lessey BA; Soper JT; McCarty KS; Haney AF
Obstet Gynecol; 1991 Nov; 78(5 Pt 2):946-50. PubMed ID: 1833687
[TBL] [Abstract][Full Text] [Related]
40. Induction of human endometrial estradiol dehydrogenase by progestins.
Tseng L; Gurpide E
Endocrinology; 1975 Oct; 97(4):825-33. PubMed ID: 172318
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
